Exploring trends in vision-threatening diabetic retinopathy over two decades

Published on May 19, 2026
Advancements in diabetes management and screening have had a “tremendous impact” on the risk of progressing to sight-threatening disease
Continue reading on website
Other news

PECAA Launches Promise Customer Brand Contact Lenses to Support Profitability and Patient Loyalty for Doctors

May 19, 2026
BOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) has launched PECAA promise, a portfolio of private label 1-day contact lenses that includes PECAA promise 1 day and PECAA promise 1 day premium, both available to PECAA Max members beginning June 1, 2026. The lenses were initially announced earlier this week on the first day of PECAA’s annual meeting. The launch aligns with PECA

Lower AMD Risk Found in Those Prescribed NSAIDs

May 20, 2026
Patients with multiple comorbidities may be subject to more frequent medical follow-up and closer monitoring, thereby increasing the likelihood of detecting both NSAID use and AMD outcomes. Click image to enlarge. While there is no cure for age-related macular degeneration (AMD), current best practice guidelines recommend lifestyle modifications for patients, such as smoking